138 related articles for article (PubMed ID: 32021085)
1. Generic Tacrolimus (Tacrobell
Kim JM; Joh JW; Choi GS; Lee SK
Drug Des Devel Ther; 2019; 13():4431-4438. PubMed ID: 32021085
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
Choi HJ; Kim DG; Kwak BJ; Han JH; Hong TH; You YK
Drug Des Devel Ther; 2018; 12():295-301. PubMed ID: 29483770
[TBL] [Abstract][Full Text] [Related]
4. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients.
Kim JM; Kwon CHD; Joh JW; Sinn DH; Choi GS; Park JB; Kang ES; Lee SK
Med Princ Pract; 2017; 26(3):221-228. PubMed ID: 28092916
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.
Heavner MS; Tichy EM; Yazdi M; Formica RN; Kulkarni S; Emre S
Am J Health Syst Pharm; 2013 Sep; 70(17):1507-12. PubMed ID: 23943182
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Early Conversion From Prograf to Generic Tacrolimus in Adult Living Donor Liver Transplant Recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Transplant Proc; 2015; 47(6):1915-6. PubMed ID: 26293073
[TBL] [Abstract][Full Text] [Related]
7. A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation.
Kim SJ; Huh KH; Han DJ; Moon IS; Kim SJ; Kim YL; Kim HC; Lee S; Kang CM; Cho BH; Kim YS
Transplant Proc; 2009 Jun; 41(5):1671-4. PubMed ID: 19545705
[TBL] [Abstract][Full Text] [Related]
8. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.
Dannhorn E; Cheung M; Rodrigues S; Cooper H; Thorburn D; Patch D; Burroughs AK; O'Beirne J
Clin Transplant; 2014 Dec; 28(12):1349-57. PubMed ID: 25142496
[TBL] [Abstract][Full Text] [Related]
9. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
Melilli E; Crespo E; Sandoval D; Manonelles A; Sala N; Mast R; Padulles A; Grinyo JM; Bestard O; Cruzado JM
Transpl Int; 2015 Nov; 28(11):1283-90. PubMed ID: 26088437
[TBL] [Abstract][Full Text] [Related]
10. Results of a phase 4 trial of Tacrobell® in liver transplantation patients: a multicenter study in South Korea.
Yu YD; Lee SG; Joh JW; Kwon CH; Kim DG; Suh KS; Lee NJ; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH
Hepatogastroenterology; 2012; 59(114):357-63. PubMed ID: 21940371
[TBL] [Abstract][Full Text] [Related]
11. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients.
Duong SQ; Lal AK; Joshi R; Feingold B; Venkataramanan R
Pediatr Transplant; 2015 Dec; 19(8):911-7. PubMed ID: 26497983
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients.
Son SY; Jang HR; Lee JE; Yoo H; Kim K; Park JB; Kim SJ; Oh HY; Huh W
Drug Des Devel Ther; 2017; 11():203-210. PubMed ID: 28138224
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
[TBL] [Abstract][Full Text] [Related]
15. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
[TBL] [Abstract][Full Text] [Related]
16. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function.
Momper JD; Ridenour TA; Schonder KS; Shapiro R; Humar A; Venkataramanan R
Am J Transplant; 2011 Sep; 11(9):1861-7. PubMed ID: 21714845
[TBL] [Abstract][Full Text] [Related]
17. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Donor Age and Recipient Characteristics on Renal Outcomes in Patients Receiving Prolonged-Release Tacrolimus After Liver Transplantation: Post-Hoc Analyses of the DIAMOND Study.
Trunečka P; Klempnauer J; Bechstein WO; Pirenne J; Bennet W; Zhao A; Isoniemi H; Rostaing L; Settmacher U; Mönch C; Brown M; Undre N; Kazeem G; Tisone G
Ann Transplant; 2019 Jun; 24():319-327. PubMed ID: 31160549
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients.
Söderlund C; Rådegran G
Clin Transplant; 2015 Jul; 29(7):619-28. PubMed ID: 25981927
[TBL] [Abstract][Full Text] [Related]
20. Physiochemical properties of generic formulations of tacrolimus in Mexico.
Petan JA; Undre N; First MR; Saito K; Ohara T; Iwabe O; Mimura H; Suzuki M; Kitamura S
Transplant Proc; 2008 Jun; 40(5):1439-42. PubMed ID: 18589125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
